SlideShare uma empresa Scribd logo
1 de 40
How Auto-Googling Can Help You


                 Or:
       Citation Metrics for Self-
             Advancement
Why Should You Want To?
• NRF rating panels now make use of h-indices
  calculated via both ISI Web of Science AND
  Scopus
• Ad Hominem Promotions Committees at UCT
  look at publication numbers and citations
• Knowing relative impacts in a field can be useful
  in rating other people objectively
• Departmental / Unit / Group reviews can be
  informed wrt numbers of papers, impacts
• Patents are an important part of your
  publications and achievements for assessment –
  and UCT keeps careful track of these
First stop: eResearch Pages
Clicking on




Takes you to
this resource
page – with a
serious
variety of
tools to
choose from
Autogoogling: needs some setting up
Autogoogling 2
To start with:
• Need a Gmail address for sign-in
• Need to train GSC as to which are your papers
What you can do:
• Immediately see your Hirsch or h-index* (which is
  usually significantly higher than the Scopus or ISI
  measure)
• See your 5-year h-index&, which is a good measure or
  your (or other person's) recent impact
*h-index is the largest number h such that h publications have at least h citations
& largest number h such that h publications have at least h new citations in the last 5 years.
Useful Google Scholar tricks
Thanks AJ Cann!
Harzing’s P or P
Publish or Perish is a software program that retrieves and analyzes academic
citations. It uses Google Scholar to obtain the raw citations, then analyzes these
for:
• Total number of papers                       Google Scholar / H or H might
• Total number of citations                    be best for:
• Average number of citations per paper        • Business, Administration,
• Average number of citations per author
• Average number of papers per author             Finance & Economics;
• Average number of citations per year         • Engineering, Computer
• Hirsch's h-index and related parameters         Science & Mathematics;
• Egghe's g-index
• The contemporary h-index                     • Social Sciences, Arts &
• The age-weighted citation rate                  Humanities.
• Two variations of individual h-indices
• An analysis of the number of authors per paper.
The results are available on-screen and can also be copied to the Windows clipboard (for
pasting into other applications) or saved
Training resources
A 15-minute audio & slide presentation on citation analysis and Publish or Perish can be
found on Slideshare.
ISI Web of Kn​owledge / Web of Science
Elsevier's Scopus
Getting in with Scopus




          Note: VERY useful for future searches
Scopus corresponds
with Google Scholar
citations for papers
UCT patent info from RCIPS
 Research Contracts and Intellectual Property Services
 Department of Research and Innovation
 2 Rhodes Avenue (Corner Main Road)
 Mowbray
 7701
                                                       Sample of printout from
  Email: Innovation@uct.ac.za                          database kept by RCIPS for
  Tel: +2721 650 4015
  Reception:+2721 650 4015
                                                       each UCT inventor
 Date: 15 October 2012


                                                       Patent Portfolio

Inventor: E.P. Rybicki

*Address 34 Uitvlugt Road, Pinelands                                   Nationality: South African
         7405
                                                                       Department: Molecular & Cell
               Ed. Rybicki@ gmail.com                                              Biology, Dept of



*Please Advise RCIPS, of any changes to your details


Status Definitions:
Patent records
 Patent Family: HIV DNA Vector                            Patent           Expression System Incorporating a
                                                          Family Title:    Capsid
                                                                           Promoter Sequence as an Enhancer of
                                                                           a Cytomegalovirus Promoter



Complete List of Inventors: Rybicki E.P., Tanzer F.L.


                    Concise listing of inventors, claims, etc
Patent
                 The amended claim set for Entry into National Phase covers the following:
Description :
                 - A method for enhancing expression of a transgene from the CMV promoter using a sequence of a
                 capsid promoter (Pcap) element or a reverse complement thereof (PcapR) which is at least 80%
                 identical to any one of the following sequences: 184 bp Pcap and PcapR fragments from PCV-1;
                 equivalent regions from the canary, goose, duck, columbid, gull, and finch circoviruses, BFDV and
                 PCV-2; linearized PCV-1 and its reverse complement; and PCV-1 Prep with deletion of the
                 Rep/Rep’ protein binding sites and 5’ truncated rep gene. The capsid promoter element or reverse
                 complement thereof can be inserted immediately upstream (5’) of the CMV promoter or up to 1100
                 bp upstream of it.

                 - The above method wherein the capsid promoter element or reverse complement thereof is from a
                 parvovirus (specifically canine parvovirus) or an anellovirus (specifically a torque teno virus or
                 torque teno mini virus).
                 - The expression cassette itself (Pcap element + CMV promoter)
                 - A vector including the expression cassette
                 - A DNA vaccine or pharmaceutical composition including the expression cassette or vector (as
- The above method wherein the capsid promoter element or reverse complement thereof is from a

                                     Patent records
               parvovirus (specifically canine parvovirus) or an anellovirus (specifically a torque teno virus or
               torque teno mini virus).
               - The expression cassette itself (Pcap element + CMV promoter)
               - A vector including the expression cassette
               - A DNA vaccine or pharmaceutical composition including the expression cassette or vector (as
               well as methods of treating HIV/AIDS etc.)
Full list of countries where filed, status, grant numbers and vital dates
                At the meeting in November 2007 to discuss the future of the SAAVI patents it was agreed that we
               should proceed to national phase with this patent in the following countries: Europe, USA, ARIPO,
               India, Namibia, SA and Brazil.

 Application Region            Application       Application             Status        Grant           Grant
 Date                          Type              Number                                Number          Date
 08-Nov-05 South Africa        Provisional       2005/09036              closed                         08-Nov-06

 08-Nov-06 PCT                 PCT               PCT/IB2006/003150      closed                          07-May-08

 08-May-08 Brazil              National Phase    PI0619665-9            Filed                           08-May-08

 08-May-08 ARIPO               National Phase    AP/P/2008/004476        Filed                          08-May-08

 08-May-08 India               National Phase    4927/DELNP/2008        Filed                           08-May-08

 08-May-08 South Africa        National Phase    2008/03928              Granted       2008/03928       30-Sep-09

 08-May-08 United States       National Phase    12/084,728              Filed                          08-May-08

 08-May-08 Europe              National Phase    06820870.1             Filed                           08-May-08
Further analysis of impact

• Deeper analysis of citations is possible using
  proprietary software. This allows:
  – Identification of multi/trans disciplinary groups
    publishing on a common theme
  – Assessment of impact of this work in terms of
    leadership of the field internationally or at UCT
  – Quick identification of international and local
    collaborators (see http://www.slideshare.net/edrybicki/uct-
    collaboration-2006-2010-res-indaba)
UCT now has Spotlight!
…so what does it do?



                       UCT Competencies: size
                       is proportional to
                       number of publications;
                       position and colours of
                       lines indicate
                       multidisciplinarity
                       (more towards middle)
Top Competencies:
Pick a Competency: a
circle is outlined and in
information window
pops up

 This one happens to
 be me and mine…
Click for more info: opens up an
          analysis page
Drill down – see how the competency
                 rates
Click into Rank Lists – see where you
           are in the world
…and where you are in your own
         institution
…and where your institution ranks
How to use this for the NRF / Faculty
• NRF Assessment Biographical info (last 8 yrs):
  “My publishing impact has increased significantly since 2003: I now
  have 137 ISI-listed publications, a h-index of 25 and over 2200
  citations, compared to a h-factor of 17, 70 publications and 783
  citations in 2002.” My research group leads the world in a
  Distinctive Competency identified by SciVal Spotlight…
• NRF Publications info: best research outputs
  Motivation                                                                   :
  This article established that, unlike previous investigations, it was possible
  to get high-level expression of HPV-16 L1 protein via transient expression
  in plants, that it assembled into VLPs, and that it elicited neutralising
  antibodies in mice. It has been cited 34 times…
• HR174           promotion              /       assessment              info
  My research group leads the world in a Distinctive Competency identified
  by SciVal Spotlight…because of my group, UCT is top in the field of
  geminivirus diversity / Jane Austen / bullfrogs….
How to do an institutional search
     Institutional / Unit / Department Review
Limit to last 5 years




Modify search query with advanced tools
Get all IIDMM publications for last 5 yrs
Look at most cited
How to use this for reviews
• Institutional address searches via Scopus (NOT
  ISI!) allow easy retrieval of papers over a given
  time period by people who would otherwise have
  been missed (or forgotten)
• The impact of the publications can very simply be
  assessed
• Cognate searches done on other Depts /
  institutes can be done as easily for comparative
  purposes: eg “we score as highly as the
  Universities of Sydney / Auckland / Hyderabad…”

Mais conteúdo relacionado

Semelhante a Self-assessment via web tools

Chi ham ip-workshop_databases_demo_chile
Chi ham ip-workshop_databases_demo_chileChi ham ip-workshop_databases_demo_chile
Chi ham ip-workshop_databases_demo_chile
Fundación COPEC - UC
 
Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015
koh tze loong
 
Nevirapine - Comprehensive patent search
Nevirapine  - Comprehensive patent searchNevirapine  - Comprehensive patent search
Nevirapine - Comprehensive patent search
ReportsnReports
 
Vemurafenib - Comprehensive patent search
Vemurafenib   - Comprehensive patent searchVemurafenib   - Comprehensive patent search
Vemurafenib - Comprehensive patent search
ReportsnReports
 
Vilazodone - Comprehensive patent search
Vilazodone  - Comprehensive patent searchVilazodone  - Comprehensive patent search
Vilazodone - Comprehensive patent search
ReportsnReports
 
IRIDA: Canada’s federated platform for genomic epidemiology
IRIDA: Canada’s federated platform for genomic epidemiology IRIDA: Canada’s federated platform for genomic epidemiology
IRIDA: Canada’s federated platform for genomic epidemiology
William Hsiao
 

Semelhante a Self-assessment via web tools (20)

Cput nrf assessment talk 2015
Cput nrf assessment talk 2015Cput nrf assessment talk 2015
Cput nrf assessment talk 2015
 
Automated and Explainable Deep Learning for Clinical Language Understanding a...
Automated and Explainable Deep Learning for Clinical Language Understanding a...Automated and Explainable Deep Learning for Clinical Language Understanding a...
Automated and Explainable Deep Learning for Clinical Language Understanding a...
 
Giab aug2015 intro and update 150821.pptx
Giab aug2015 intro and update 150821.pptxGiab aug2015 intro and update 150821.pptx
Giab aug2015 intro and update 150821.pptx
 
Funding data for research
Funding data for researchFunding data for research
Funding data for research
 
Technology Trend Analysis of R&D Strategy on iPS Cells
Technology Trend Analysis of R&D Strategy on iPS CellsTechnology Trend Analysis of R&D Strategy on iPS Cells
Technology Trend Analysis of R&D Strategy on iPS Cells
 
Chi ham ip-workshop_databases_demo_chile
Chi ham ip-workshop_databases_demo_chileChi ham ip-workshop_databases_demo_chile
Chi ham ip-workshop_databases_demo_chile
 
Euretos presentation ACS
Euretos presentation ACSEuretos presentation ACS
Euretos presentation ACS
 
Brand specificities and study tools developed by DRIVE
Brand specificities and study tools developed by DRIVE Brand specificities and study tools developed by DRIVE
Brand specificities and study tools developed by DRIVE
 
Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015Koh Tze Loong CV for pharma Nov 2015
Koh Tze Loong CV for pharma Nov 2015
 
Sistemas de Gestão de Ciência e Repositórios - Diretrizes nacionais e interna...
Sistemas de Gestão de Ciência e Repositórios - Diretrizes nacionais e interna...Sistemas de Gestão de Ciência e Repositórios - Diretrizes nacionais e interna...
Sistemas de Gestão de Ciência e Repositórios - Diretrizes nacionais e interna...
 
NRNB EAC Meeting 2012
NRNB EAC Meeting 2012NRNB EAC Meeting 2012
NRNB EAC Meeting 2012
 
Nevirapine - Comprehensive patent search
Nevirapine  - Comprehensive patent searchNevirapine  - Comprehensive patent search
Nevirapine - Comprehensive patent search
 
The EC/OpenAIRE FP7 Post-Grant Open Access Pilot: An Update for the Nordic NOADs
The EC/OpenAIRE FP7 Post-Grant Open Access Pilot: An Update for the Nordic NOADsThe EC/OpenAIRE FP7 Post-Grant Open Access Pilot: An Update for the Nordic NOADs
The EC/OpenAIRE FP7 Post-Grant Open Access Pilot: An Update for the Nordic NOADs
 
Dr. Lisa Becton - Update on PEDV Research
Dr. Lisa Becton - Update on PEDV ResearchDr. Lisa Becton - Update on PEDV Research
Dr. Lisa Becton - Update on PEDV Research
 
Analyze Genomes: A Federated In-Memory Database System For Life Sciences
Analyze Genomes: A Federated In-Memory Database System For Life SciencesAnalyze Genomes: A Federated In-Memory Database System For Life Sciences
Analyze Genomes: A Federated In-Memory Database System For Life Sciences
 
Lessons learnt from the GCP experience – J-M Ribaut
Lessons learnt from the GCP experience – J-M RibautLessons learnt from the GCP experience – J-M Ribaut
Lessons learnt from the GCP experience – J-M Ribaut
 
Vemurafenib - Comprehensive patent search
Vemurafenib   - Comprehensive patent searchVemurafenib   - Comprehensive patent search
Vemurafenib - Comprehensive patent search
 
TranSMART: How open source software revolutionizes drug discovery through cro...
TranSMART: How open source software revolutionizes drug discovery through cro...TranSMART: How open source software revolutionizes drug discovery through cro...
TranSMART: How open source software revolutionizes drug discovery through cro...
 
Vilazodone - Comprehensive patent search
Vilazodone  - Comprehensive patent searchVilazodone  - Comprehensive patent search
Vilazodone - Comprehensive patent search
 
IRIDA: Canada’s federated platform for genomic epidemiology
IRIDA: Canada’s federated platform for genomic epidemiology IRIDA: Canada’s federated platform for genomic epidemiology
IRIDA: Canada’s federated platform for genomic epidemiology
 

Mais de Edward Rybicki

Research Portal Update - Humanities and CHED, July 2013
Research Portal Update - Humanities and CHED, July 2013Research Portal Update - Humanities and CHED, July 2013
Research Portal Update - Humanities and CHED, July 2013
Edward Rybicki
 
Uct collaboration 2006 2010 - res indaba
Uct collaboration 2006 2010 - res indabaUct collaboration 2006 2010 - res indaba
Uct collaboration 2006 2010 - res indaba
Edward Rybicki
 

Mais de Edward Rybicki (13)

All you (never) wanted to know about COVID-19 and SARS-CoV-2
All you (never) wanted to know about COVID-19 and SARS-CoV-2All you (never) wanted to know about COVID-19 and SARS-CoV-2
All you (never) wanted to know about COVID-19 and SARS-CoV-2
 
Research portal Commerce Faculty 11 09-2013
Research portal Commerce Faculty 11 09-2013Research portal Commerce Faculty 11 09-2013
Research portal Commerce Faculty 11 09-2013
 
Why to use social media, for scientists
Why to use social media, for scientistsWhy to use social media, for scientists
Why to use social media, for scientists
 
Research Portal Update - Humanities and CHED, July 2013
Research Portal Update - Humanities and CHED, July 2013Research Portal Update - Humanities and CHED, July 2013
Research Portal Update - Humanities and CHED, July 2013
 
Res portal 16 5-2012
Res portal 16 5-2012Res portal 16 5-2012
Res portal 16 5-2012
 
Uct collaboration 2006 2010 - res indaba
Uct collaboration 2006 2010 - res indabaUct collaboration 2006 2010 - res indaba
Uct collaboration 2006 2010 - res indaba
 
Res portal open uct
Res portal open uctRes portal open uct
Res portal open uct
 
Ref man talk 2012
Ref man talk 2012Ref man talk 2012
Ref man talk 2012
 
Ref works 2011
Ref works 2011Ref works 2011
Ref works 2011
 
Collaboration tool in SciVal Spotlight
Collaboration tool in SciVal SpotlightCollaboration tool in SciVal Spotlight
Collaboration tool in SciVal Spotlight
 
Spotlight rollout
Spotlight rolloutSpotlight rollout
Spotlight rollout
 
Research portal ideas
Research portal ideasResearch portal ideas
Research portal ideas
 
Sci val multidisc sept 2011
Sci val multidisc sept 2011Sci val multidisc sept 2011
Sci val multidisc sept 2011
 

Self-assessment via web tools

  • 1. How Auto-Googling Can Help You Or: Citation Metrics for Self- Advancement
  • 2. Why Should You Want To? • NRF rating panels now make use of h-indices calculated via both ISI Web of Science AND Scopus • Ad Hominem Promotions Committees at UCT look at publication numbers and citations • Knowing relative impacts in a field can be useful in rating other people objectively • Departmental / Unit / Group reviews can be informed wrt numbers of papers, impacts • Patents are an important part of your publications and achievements for assessment – and UCT keeps careful track of these
  • 4.
  • 5. Clicking on Takes you to this resource page – with a serious variety of tools to choose from
  • 7. Autogoogling 2 To start with: • Need a Gmail address for sign-in • Need to train GSC as to which are your papers What you can do: • Immediately see your Hirsch or h-index* (which is usually significantly higher than the Scopus or ISI measure) • See your 5-year h-index&, which is a good measure or your (or other person's) recent impact *h-index is the largest number h such that h publications have at least h citations & largest number h such that h publications have at least h new citations in the last 5 years.
  • 10.
  • 11. Harzing’s P or P Publish or Perish is a software program that retrieves and analyzes academic citations. It uses Google Scholar to obtain the raw citations, then analyzes these for: • Total number of papers Google Scholar / H or H might • Total number of citations be best for: • Average number of citations per paper • Business, Administration, • Average number of citations per author • Average number of papers per author Finance & Economics; • Average number of citations per year • Engineering, Computer • Hirsch's h-index and related parameters Science & Mathematics; • Egghe's g-index • The contemporary h-index • Social Sciences, Arts & • The age-weighted citation rate Humanities. • Two variations of individual h-indices • An analysis of the number of authors per paper. The results are available on-screen and can also be copied to the Windows clipboard (for pasting into other applications) or saved Training resources A 15-minute audio & slide presentation on citation analysis and Publish or Perish can be found on Slideshare.
  • 12. ISI Web of Kn​owledge / Web of Science
  • 13.
  • 14.
  • 16. Getting in with Scopus Note: VERY useful for future searches
  • 17.
  • 18.
  • 19.
  • 20. Scopus corresponds with Google Scholar citations for papers
  • 21. UCT patent info from RCIPS Research Contracts and Intellectual Property Services Department of Research and Innovation 2 Rhodes Avenue (Corner Main Road) Mowbray 7701 Sample of printout from Email: Innovation@uct.ac.za database kept by RCIPS for Tel: +2721 650 4015 Reception:+2721 650 4015 each UCT inventor Date: 15 October 2012 Patent Portfolio Inventor: E.P. Rybicki *Address 34 Uitvlugt Road, Pinelands Nationality: South African 7405 Department: Molecular & Cell Ed. Rybicki@ gmail.com Biology, Dept of *Please Advise RCIPS, of any changes to your details Status Definitions:
  • 22. Patent records Patent Family: HIV DNA Vector Patent Expression System Incorporating a Family Title: Capsid Promoter Sequence as an Enhancer of a Cytomegalovirus Promoter Complete List of Inventors: Rybicki E.P., Tanzer F.L. Concise listing of inventors, claims, etc Patent The amended claim set for Entry into National Phase covers the following: Description : - A method for enhancing expression of a transgene from the CMV promoter using a sequence of a capsid promoter (Pcap) element or a reverse complement thereof (PcapR) which is at least 80% identical to any one of the following sequences: 184 bp Pcap and PcapR fragments from PCV-1; equivalent regions from the canary, goose, duck, columbid, gull, and finch circoviruses, BFDV and PCV-2; linearized PCV-1 and its reverse complement; and PCV-1 Prep with deletion of the Rep/Rep’ protein binding sites and 5’ truncated rep gene. The capsid promoter element or reverse complement thereof can be inserted immediately upstream (5’) of the CMV promoter or up to 1100 bp upstream of it. - The above method wherein the capsid promoter element or reverse complement thereof is from a parvovirus (specifically canine parvovirus) or an anellovirus (specifically a torque teno virus or torque teno mini virus). - The expression cassette itself (Pcap element + CMV promoter) - A vector including the expression cassette - A DNA vaccine or pharmaceutical composition including the expression cassette or vector (as
  • 23. - The above method wherein the capsid promoter element or reverse complement thereof is from a Patent records parvovirus (specifically canine parvovirus) or an anellovirus (specifically a torque teno virus or torque teno mini virus). - The expression cassette itself (Pcap element + CMV promoter) - A vector including the expression cassette - A DNA vaccine or pharmaceutical composition including the expression cassette or vector (as well as methods of treating HIV/AIDS etc.) Full list of countries where filed, status, grant numbers and vital dates At the meeting in November 2007 to discuss the future of the SAAVI patents it was agreed that we should proceed to national phase with this patent in the following countries: Europe, USA, ARIPO, India, Namibia, SA and Brazil. Application Region Application Application Status Grant Grant Date Type Number Number Date 08-Nov-05 South Africa Provisional 2005/09036 closed 08-Nov-06 08-Nov-06 PCT PCT PCT/IB2006/003150 closed 07-May-08 08-May-08 Brazil National Phase PI0619665-9 Filed 08-May-08 08-May-08 ARIPO National Phase AP/P/2008/004476 Filed 08-May-08 08-May-08 India National Phase 4927/DELNP/2008 Filed 08-May-08 08-May-08 South Africa National Phase 2008/03928 Granted 2008/03928 30-Sep-09 08-May-08 United States National Phase 12/084,728 Filed 08-May-08 08-May-08 Europe National Phase 06820870.1 Filed 08-May-08
  • 24. Further analysis of impact • Deeper analysis of citations is possible using proprietary software. This allows: – Identification of multi/trans disciplinary groups publishing on a common theme – Assessment of impact of this work in terms of leadership of the field internationally or at UCT – Quick identification of international and local collaborators (see http://www.slideshare.net/edrybicki/uct- collaboration-2006-2010-res-indaba)
  • 25. UCT now has Spotlight!
  • 26. …so what does it do? UCT Competencies: size is proportional to number of publications; position and colours of lines indicate multidisciplinarity (more towards middle)
  • 28. Pick a Competency: a circle is outlined and in information window pops up This one happens to be me and mine…
  • 29. Click for more info: opens up an analysis page
  • 30. Drill down – see how the competency rates
  • 31. Click into Rank Lists – see where you are in the world
  • 32. …and where you are in your own institution
  • 33. …and where your institution ranks
  • 34. How to use this for the NRF / Faculty • NRF Assessment Biographical info (last 8 yrs): “My publishing impact has increased significantly since 2003: I now have 137 ISI-listed publications, a h-index of 25 and over 2200 citations, compared to a h-factor of 17, 70 publications and 783 citations in 2002.” My research group leads the world in a Distinctive Competency identified by SciVal Spotlight… • NRF Publications info: best research outputs Motivation : This article established that, unlike previous investigations, it was possible to get high-level expression of HPV-16 L1 protein via transient expression in plants, that it assembled into VLPs, and that it elicited neutralising antibodies in mice. It has been cited 34 times… • HR174 promotion / assessment info My research group leads the world in a Distinctive Competency identified by SciVal Spotlight…because of my group, UCT is top in the field of geminivirus diversity / Jane Austen / bullfrogs….
  • 35. How to do an institutional search Institutional / Unit / Department Review
  • 36.
  • 37. Limit to last 5 years Modify search query with advanced tools
  • 38. Get all IIDMM publications for last 5 yrs
  • 39. Look at most cited
  • 40. How to use this for reviews • Institutional address searches via Scopus (NOT ISI!) allow easy retrieval of papers over a given time period by people who would otherwise have been missed (or forgotten) • The impact of the publications can very simply be assessed • Cognate searches done on other Depts / institutes can be done as easily for comparative purposes: eg “we score as highly as the Universities of Sydney / Auckland / Hyderabad…”